|
[4]
|
AMITRAZ
|
From 3 to 6 applications at 14-days intervals.
|
3
|
2
|
3
|
|
[8]
|
IMIDACLOPRID+MOXIDECTIN
|
From 2 to 4 applications at 28-days intervals.
|
3
|
2
|
3
|
|
[11]
|
IMIDACLOPRID+MOXIDECTIN
|
Group 1 treated at 28-days intervals max 4 times; group 2 at 7-days intervals max 16 times.
|
2
|
1
|
3 (Group 1) 3 (Group 2)
|
|
[14]
|
FIPRONIL + METHOPRENE + AMITRAZ
|
Group 1 treated at 28-days intervals; group 2 treated at 14-days intervals.
|
3
|
2
|
3 (Group 1) 3 (Group 2)
|
|
[14]
|
METAFLUMIZONE + AMITRAZ
|
Group 3 treated at 28-days intervals.
|
3
|
2
|
3
|
|
[16]
|
IMIDACLOPRID+MOXIDECTIN
|
ADV1 treated monthly; ADV2 biweekly; ADV4 weekly.
|
3
|
2
|
1 (ADV1) 2 (ADV2) AND 3 (ADV4)
|
|
[17]
|
IMIDACLOPRID+MOXIDECTIN
|
ADV1 treated monthly; ADV2 biweekly; ADV4 weekly.
|
3
|
1
|
1 (ADV1) 2 (ADV2) AND 3 (ADV3)
|
|
[18]
|
IMIDACLOPRID+MOXIDECTIN
|
3 applications at 28-days intervals.
|
3
|
2
|
3
|
|
[19]
|
IMIDACLOPRID+MOXIDECTIN
|
Weekly from day 0 to day 81.
|
3
|
2
|
3
|
|
[20]
|
IMIDACLOPRID+MOXIDECTIN
|
4 applications at 14-days intervals.
|
3
|
2
|
3
|
|
[23]
|
IMIDACLOPRID+MOXIDECTIN
|
From 2 to 6 applications at 7 or 28-days intervals
|
3
|
2
|
3
|
